Found: 12
Select item for more details and to access through your institution.
Analyzing the immunogenicity of bivalent booster vaccinations in healthcare workers: The SWITCH ON trial protocol.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1067749
- By:
- Publication type:
- Article
Durability of Immune Responses After Boosting in Ad26.COV2.S-Primed Healthcare Workers.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 3, p. e533, doi. 10.1093/cid/ciac495
- By:
- Publication type:
- Article
Evaluation of a group-based online informed consent conversation (eConsent) in participants from a low-risk vaccination clinical trial.
- Published in:
- Trials, 2024, p. 1, doi. 10.1186/s13063-024-08367-4
- By:
- Publication type:
- Article
Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-48414-x
- By:
- Publication type:
- Article
No association between use of angiotensin‐converting enzyme inhibitors or angiotensin II receptor blockers prior to hospital admission and clinical course of COVID‐19 in the COvid MEdicaTion (COMET) study.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 8, p. 3301, doi. 10.1111/bcp.14751
- By:
- Publication type:
- Article
Combined use of polypill components in patients with type 2 diabetes mellitus.
- Published in:
- European Journal of Preventive Cardiology, 2018, v. 25, n. 14, p. 1523, doi. 10.1177/2047487318789494
- By:
- Publication type:
- Article
Impact of switching from different treatment regimens to a fixed-dose combination pill (polypill) in patients with cardiovascular disease or similarly high risk: The influence of baseline medication on LDL-cholesterol, blood pressure and calculated risk reduction when switching to a cardiovascular polypill
- Published in:
- European Journal of Preventive Cardiology, 2017, v. 24, n. 9, p. 951, doi. 10.1177/2047487317695616
- By:
- Publication type:
- Article
Estimated cardiovascular relative risk reduction from fixed-dose combination pill (polypill) treatment in a wide range of patients with a moderate risk of cardiovascular disease.
- Published in:
- European Journal of Preventive Cardiology, 2016, v. 23, n. 12, p. 1289, doi. 10.1177/2047487315624523
- By:
- Publication type:
- Article
The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) in clinical practice in patients with vascular diseases or type 2 diabetes mellitus.
- Published in:
- European Journal of Preventive Cardiology, 2013, v. 20, n. 5, p. 771, doi. 10.1177/2047487312449587
- By:
- Publication type:
- Article
PCSK9-remmers bij familiaire hypercholesterolemie.
- Published in:
- Geneesmiddelenbulletin, 2021, n. 10, p. 1
- By:
- Publication type:
- Article
Negatieve invloed geneesmiddelen op COVID-19.
- Published in:
- Geneesmiddelenbulletin, 2020, n. 4, p. 1
- By:
- Publication type:
- Article
Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial Protocol.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.753319
- By:
- Publication type:
- Article